Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria

Información del proyecto

MultiViVax

Identificador del acuerdo de subvención: 733073

DOI

10.3030/733073

Proyecto cerrado

Fecha de la firma de la CE 9 Diciembre 2016

Fecha de inicio 1 Enero 2017

Fecha de finalización 31 Diciembre 2022

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total

€ 5 736 576,25

Aportación de la UE

€ 5 058 974,00

Coordinado por

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (10)

Report of final meeting and list of publications
Establish and qualify SMFA using the transgenic parasite

Establish and qualify SMFA using the transgenic parasite PfPvs25

Report on the analysis of CHMI serological immuno-profiling

Report on the analysis of CHMI serological immunoprofiling

Report on the safety, immunogenicity and efficacy of ChAd-MVA PvDBP_RII against blood-stage parasite challenge in a Phase I/IIa efficacy trial VAC071A/B

Report on the safety immunogenicity and efficacy of ChAdMVA PvDBPRII against bloodstage parasite challenge in a Phase IIIa efficacy trial VAC071AB

Assessment of GIA of new candidate antigens using novel transgenic P. knowlesi parasites

Assessment of GIA of new candidate antigens using novel transgenic P knowlesi parasites

Report on the safety, immunogenicity and immuno-efficacy of Pvs25-IMX313 in Matrix-M1 adjuvant

Report on the safety immunogenicity and immunoefficacy of Pvs25IMX313 in MatrixM1 adjuvant for transmissionblocking vaccine clinical trial

Establish transgenic P. knowlesi GIA assay methodology and assess blood-stage clinical trial samples
Generation and fitness assessment of transgenic parasite Pf-Pvs25

Generation and fitness assessment of transgenic parasite Pf-Pvs25 to develop SMFA assay

Report on the analysis of RNAseq datasets
Report on the safety, efficacy and transmissibility of homologous secondary and tertiary re-infection in all three groups with blood-stage P. vivax in a CHMI model (VAC069A-F).

Report on the safety efficacy and transmissibility of homologous secondary and tertiary reinfection in all three groups with bloodstage P vivax in a CHMI model VAC069AF

Websites, patent fillings, videos etc. (1)

Description of website

Publicaciones

Peer reviewed articles (4)

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody

Autores: Thomas. A. Rawlinson, Natalie M. Barber, Franziska Mohring, Jee Sun Cho, Varakorn Kosaisavee, Samuel F. Gérard, Daniel G. W. Alanine, Geneviève M. Labbé, Sean C. Elias, Sarah E. Silk, Doris Quinkert, Jing Jin, Jennifer M. Marshall, Ruth O. Payne, Angela M. Minassian, Bruce Russell, Laurent Rénia, François H. Nosten, Robert W. Moon, Matthew K. Higgins, Simon J. Draper
Publicado en: Nature Microbiology, Edición 4/9, 2019, Página(s) 1497-1507, ISSN 2058-5276
Editor: Nature Research
DOI: 10.1038/s41564-019-0462-1

Multiplication and Growth Inhibition Activity Assays for the Zoonotic Malaria Parasite, Plasmodium knowlesi

Autores: Franziska Mohring1, Thomas A. Rawlinson2, Simon J. Draper2 and Robert W. Moon
Publicado en: National Library of Medicine, 2020, ISSN 2331-8325
Editor: Bio-protocol
DOI: 10.21769/bioprotoc.3743

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection

Autores: Mimi M. Hou1,2,3, Jordan R. Barrett1,2,3, Yrene Themistocleous2, Thomas A. Rawlinson2, Ababacar Diouf4, Francisco J. Martinez5, Carolyn M. Nielsen1,2,3, Amelia M. Lias1,2,3, Lloyd D. W. King1,2,3, Nick J. Edwards2, Nicola M. Greenwood2, Lucy Kingham2, Ian D. Poulton2, Baktash Khozoee2, Cyndi Goh2, Susanne H. Hodgson1,2,3, Dylan J. Mac Lochlainn1,2,3, Jo Salkeld1,2,3, Micheline Guillotte-Blisni
Publicado en: National Library of Medicine, 2023, ISSN 1946-6234
Editor: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.adf1782

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly

Autores: Angela M. Minassian, Yrene Themistocleous, Sarah E. Silk, Jordan R. Barrett, Alison Kemp, Doris Quinkert, Carolyn M. Nielsen, Nick J. Edwards, Thomas A. Rawlinson, Fernando Ramos Lopez, Wanlapa Roobsoong, Katherine J.D. Ellis, Jee-Sun Cho, Eerik Aunin, Thomas D. Otto, Adam J. Reid, Florian A. Bach, Geneviève M.C. Labbé, Ian D. Poulton, Arianna Marini, Marija Zaric, Margaux Mulatier, Raquel Lopez
Publicado en: National Library of Medicine, 2021, ISSN 2379-3708
Editor: JCI insight
DOI: 10.1172/jci.insight.152465